Replies to post #621187 on NorthWest Biotherapeutics Inc (NWBO)

[supersteve13]

Optune was approved in rGBM with zero OS benefit from the EF-11 study. Compare that to the DCVax data. :)

Avastin was approved on ORR only from two single arm studies, one with 78 patients and one with 56, and with grade 3-5 AEs in the first study (hemorrhage, CNS hemorrhage, hypertension, perforation, etc)